Goldman Sachs’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,195
| Closed | -$135K | – | 5550 |
|
|
2021
Q3 | $135K | Buy |
2,195
+379
| +21% | +$23.3K | ﹤0.01% | 4990 |
|
|
2021
Q2 | $141K | Sell |
1,816
-187
| -9% | -$14.5K | ﹤0.01% | 5035 |
|
|
2021
Q1 | $112K | Buy |
2,003
+163
| +9% | +$9.11K | ﹤0.01% | 5004 |
|
|
2020
Q4 | $112K | Buy |
1,840
+1,106
| +151% | +$67.3K | ﹤0.01% | 4455 |
|
|
2020
Q3 | $89K | Sell |
734
-826
| -53% | -$100K | ﹤0.01% | 4248 |
|
|
2020
Q2 | $184K | Buy |
1,560
+636
| +69% | +$75K | ﹤0.01% | 4009 |
|
|
2020
Q1 | $49K | Sell |
924
-1,088
| -54% | -$57.7K | ﹤0.01% | 4279 |
|
|
2019
Q4 | $109K | Sell |
2,012
-377
| -16% | -$20.4K | ﹤0.01% | 4120 |
|
|
2019
Q3 | $579K | Sell |
2,389
-1,499
| -39% | -$363K | ﹤0.01% | 3528 |
|
|
2019
Q2 | $890K | Buy |
+3,888
| New | +$890K | ﹤0.01% | 3250 |
|